A study of first line therapy with esomeprazol for Helicobacter pylori eradication

A study of first line therapy with esomeprazol for Helicobacter pylori eradication - Helicobacter pylori eradication therapy with esomeprazol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009642

Enrollment

Registered

2013-01-01

Start date

2013-01-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H.pylori infection

Interventions

H.pylori eradication therapy with esomeprazol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: H.pylori positive

Exclusion criteria

Exclusion criteria: Drug allergy Operation for GI tract Peptic ulcer

Design outcomes

Primary

Measure	Time frame
eradication rate	—

Countries

Japan

Contacts

Public ContactYoshimasa Saito

Kitasato University Kitasato Institute Hospital Division of Gastroenterology and Hepatology

yoshimasa.saito@gmail.com03-3444-6161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026